This strategy was also used to modify the dipeptidyl peptidase-4 gene (DPP-4) to upregulate the glucagon-like peptide 1 in a murine model of type 2 diabetes mellitus (T2DM) db/db mice. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.